Skip to content

Euclidean Capital LLC

Follow

13F filer, CIK 1825034, NEW YORK, NY

Euclidean Capital LLC reported $323,634,131 across 10 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001012975-26-001061

Period
2026-09-30
Reported value
$324M
Holdings
10
Top 10 weight
100%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MRLNnew+47,610$89.5K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VTVexited-520,000-$113M
SRZNWexited-170,833-$2.82K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001012975-26-001061, largest first. % of portfolio is the value over $323,634,131, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VEUVANGUARD INTL EQUITY INDEX FQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,013,434 shares; 2025Q1: 1,991,884 shares; 2025Q2: 2,142,684 shares; 2025Q3: 2,578,184 shares; 2025Q4: 2,990,084 shares; 2026Q1: 3,243,484 shares; 2026Q2: 3,243,484 shares; 2026Q3: 3,243,484 shares 3,243,484$269M83.15%0Timeline
INDAISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,425,144 shares; 2025Q1: 2,425,144 shares; 2025Q2: 2,425,144 shares; 2025Q3: 369,600 shares; 2025Q4: 369,600 shares; 2026Q1: 369,600 shares; 2026Q2: 369,600 shares; 2026Q3: 369,600 shares 369,600$17.3M5.33%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 989,410 shares; 2025Q1: 989,410 shares; 2025Q2: 989,410 shares; 2025Q3: 989,410 shares; 2025Q4: 989,410 shares; 2026Q1: 989,410 shares; 2026Q2: 989,410 shares; 2026Q3: 989,410 shares 989,410$13.3M4.12%0Timeline
TMSTEAMSHARES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,099,974 shares; 2026Q3: 1,099,974 shares 1,099,974$7.99M2.47%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,573,761 shares; 2025Q1: 1,573,761 shares; 2025Q2: 1,573,761 shares; 2025Q3: 1,573,761 shares; 2025Q4: 1,573,761 shares; 2026Q1: 1,573,761 shares; 2026Q2: 1,573,761 shares; 2026Q3: 1,573,761 shares 1,573,761$5.62M1.74%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,627,643 shares; 2025Q1: 2,627,643 shares; 2025Q2: 2,627,643 shares; 2025Q3: 2,627,643 shares; 2025Q4: 2,627,643 shares; 2026Q1: 2,627,643 shares; 2026Q2: 2,627,643 shares; 2026Q3: 2,627,643 shares 2,627,643$4.39M1.36%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 87,696 shares; 2025Q1: 87,696 shares; 2025Q2: 87,696 shares; 2025Q3: 87,696 shares; 2025Q4: 87,696 shares; 2026Q1: 87,696 shares; 2026Q2: 87,696 shares; 2026Q3: 87,696 shares 87,696$2.82M0.87%0Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,307,858 shares; 2025Q1: 1,307,858 shares; 2025Q2: 1,307,858 shares; 2025Q3: 1,307,858 shares; 2025Q4: 1,307,858 shares; 2026Q1: 1,307,858 shares; 2026Q2: 1,307,858 shares; 2026Q3: 1,307,858 shares 1,307,858$2.42M0.75%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,015,705 shares; 2025Q1: 1,015,705 shares; 2025Q2: 1,015,705 shares; 2025Q3: 1,015,705 shares; 2025Q4: 1,015,705 shares; 2026Q1: 1,015,705 shares; 2026Q2: 1,015,705 shares; 2026Q3: 1,015,705 shares 1,015,705$613K0.19%0Timeline
MRLNMERLIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 47,610 shares 47,610$89.5K0.03%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VTVVANGUARD INDEX FDS520,000$113Mshares
SRZNWSURROZEN INC170,833$2.82Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-001061 base2026-11-16